Australian radiopharma company Telix Pharmaceuticals Ltd. announced it is acquiring its partner, Belgium-based Advanced Nuclear Medicine Ingredients (Anmi) SA, for roughly A$8.1 million (US$5.9 million) in cash and Telix shares. The move accelerates commercialization of Telix's prostate cancer diagnostic kit, Illumet, in the U.S. and Europe.
Australian radiopharma company Telix Pharmaceuticals Ltd. announced it is acquiring its partner, Belgium-based Advanced Nuclear Medicine Ingredients (Anmi) SA, for roughly A$8.1 million (US$5.9 million) in cash and Telix shares. The move accelerates commercialization of Telix's prostate cancer diagnostic kit, Illumet, in the U.S. and Europe.
BRISBANE, Australia – A "world-first" clinical trial of a new immunotherapy to treat multiple sclerosis (MS) showed improved symptoms and improvement in the quality of life for the majority of patients.
BRISBANE, Australia – A "world-first" clinical trial of a new immunotherapy to treat multiple sclerosis (MS) showed improved symptoms and improvement in the quality of life for the majority of patients.
PERTH, Australia – Brisbane, Australia-based Factor Therapeutics Ltd. is stopping all development of VF-001 after a phase II trial in venous leg ulcer healing failed to meet all endpoints, which included reduction in wound size, proportion of patients with ulcers fully healed and time to achieve full wound healing.
PERTH, Australia – Australia is rolling out a nationwide electronic health record (EHR) portal, called My Health Record under which patients will be able to access their health data any time and take the information with them when they move.
